一种低剂量避孕药——妈富隆的临床研究
[Clinical study of a low-dose contraceptive--Femodene].
作者信息
Rachev E, Damianov L, Dukovski A, Katsarova M
出版信息
Akush Ginekol (Sofiia). 1995;34(3):71-3.
PMID:8787249
Abstract
The authors present their clinical experience with a low-dose monophasic contraceptive consisting of 30 mcg ethinylestradiol and 75 mcg a gestagen--gestodene (Femoden, Schering). 112 menstrual cycles of 22 women in fertile age were followed. The results show 100% contraception, a good control of the menstrual cycle and tolerance of the preparation.
摘要
作者介绍了他们使用一种低剂量单相避孕药的临床经验，该避孕药由30微克炔雌醇和75微克孕二烯酮（去氧孕烯，先灵公司产品）组成。对22名育龄妇女的112个月经周期进行了跟踪观察。结果显示避孕成功率达100%，月经周期得到良好控制，且该制剂耐受性良好。
Zotero 插件